Patent · US Active

Compositions and methods of treating cardiac fibrosis with ifetroban

US10016399B2 · kind B2 · utility

0Cited by
16References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 30, 2017
Grant dateJul 10, 2018
Priority date
Expiry dateMay 30, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.